bupranolol has been researched along with brl 37344 in 22 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 11 (50.00) | 18.2507 |
2000's | 10 (45.45) | 29.6817 |
2010's | 1 (4.55) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blin, N; Camoin, L; Maigret, B; Strosberg, AD | 1 |
Guillaume, JL; Méjean, A; Strosberg, AD | 1 |
Berlan, M; Bousquet-Melou, A; Galitzky, J; Lafontan, M; Montastruc, JL | 1 |
Berlan, M; Carpéné, C; Galitzky, J; Lafontan, M; Portillo, M; Reverte, M | 1 |
Ichino, T; Koike, K; Koshikawa, H; Nagatomo, T; Takayanagi, I | 1 |
Bar-Ilan, A; Geyer, O; Lazar, M; Nachman, R; Oron, Y | 1 |
Gerhardt, CC; Gros, J; Issad, T; Strosberg, AD | 1 |
Atgié, C; Berlan, M; Carpéné, C; Fontana, E; Galitzky, J; Lafontan, M | 1 |
Horinouchi, T; Koike, K; Koshikawa, H | 1 |
Horinouchi, T; Koike, K | 5 |
Horinouchi, T; Koike, K; Tsujitani, M | 1 |
Brahmadevara, N; MacDonald, A; Shaw, AM | 1 |
Balligand, JL; Dessy, C; Ghisdal, P; Havaux, X; Moniotte, S; Noirhomme, P | 1 |
Canová, N; Farghali, H; Lincová, D | 1 |
Ivorra, MD; Leblais, V; Marthan, R; Muller, B; Pourageaud, F | 1 |
Doheny, HC; Lynch, CM; Morrison, JJ; Smith, TJ | 1 |
Clouse, AK; Hieble, JP; Riedel, E; Westfall, TD | 1 |
Jaroszewski, JJ; Markiewicz, W | 1 |
22 other study(ies) available for bupranolol and brl 37344
Article | Year |
---|---|
Structural and conformational features determining selective signal transduction in the beta 3-adrenergic receptor.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; CHO Cells; Cricetinae; GTP-Binding Proteins; Humans; Models, Molecular; Protein Conformation; Receptors, Adrenergic, beta; Signal Transduction; Structure-Activity Relationship | 1993 |
Carazolol: a potent, selective beta 3-adrenoceptor agonist.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Binding, Competitive; Cells, Cultured; CHO Cells; Cricetinae; Dithiothreitol; Lipolysis; Propanolamines; Receptors, Adrenergic, beta | 1995 |
Beta-3 adrenoceptor-mediated increase in cutaneous blood flow in the dog.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Bupranolol; Dioxoles; Dogs; Ethanolamines; Heart Rate; Isoproterenol; Male; Nitroprusside; Propanolamines; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-3; Regional Blood Flow; Skin | 1994 |
Coexistence of beta 1-, beta 2-, and beta 3-adrenoceptors in dog fat cells and their differential activation by catecholamines.
Topics: Adenylyl Cyclases; Adipose Tissue; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Catecholamines; Cell Membrane; Dogs; Dose-Response Relationship, Drug; Epinephrine; Ethanolamines; Isoproterenol; Norepinephrine; Procaterol; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Tetrahydronaphthalenes | 1993 |
Beta3-adrenoceptors mediate relaxation of guinea pig taenia caecum by BRL37344A and BRL35135A.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Cecum; Dose-Response Relationship, Drug; Ethanolamines; Guinea Pigs; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth; Phenethylamines; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-3 | 1997 |
Beta3-adrenergic relaxation of bovine iris sphincter.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Animals; Bupranolol; Cattle; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Ethanolamines; Iris; Isoproterenol; Muscle Relaxation; Muscle, Smooth; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-3 | 1998 |
Stimulation of the extracellular signal-regulated kinase 1/2 pathway by human beta-3 adrenergic receptor: new pharmacological profile and mechanism of activation.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Calcium-Calmodulin-Dependent Protein Kinases; CHO Cells; Colforsin; Cricetinae; Dioxoles; Enzyme Activation; Epinephrine; Ethanolamines; Humans; Insulin; Isoproterenol; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Norepinephrine; Phentolamine; Prazosin; Propanolamines; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-3; Signal Transduction; Yohimbine | 1999 |
Selective activation of beta3-adrenoceptors by octopamine: comparative studies in mammalian fat cells.
Topics: Adipose Tissue; Adipose Tissue, Brown; Adrenergic beta-Agonists; Adult; Animals; Binding, Competitive; Biogenic Amines; Bupranolol; CHO Cells; Cricetinae; Dioxoles; Dogs; Ethanolamines; Female; Gene Expression; Guinea Pigs; Humans; Imidazoles; Iodine Radioisotopes; Iodocyanopindolol; Isoproterenol; Lipolysis; Male; Mammals; Mesocricetus; Norepinephrine; Octopamine; Oxygen Consumption; Propanolamines; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3; Species Specificity | 1999 |
Effect of bupranolol for BRL37344 and noradrenaline-induced relaxations mediating atypical beta/beta3-adrenoceptor in rat oesophageal muscularis mucosae.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Esophagus; Ethanolamines; Male; Mucous Membrane; Muscle Relaxation; Norepinephrine; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-3 | 1999 |
Pharmacological analysis of atypical beta-adrenoceptors in the guinea pig gastric fundus using the beta(3)-adrenoceptor antagonist bupranolol.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atenolol; Bupranolol; Butoxamine; Catecholamines; Dose-Response Relationship, Drug; Epinephrine; Ethanolamines; Gastric Fundus; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Muscle Contraction; Muscle Relaxation; Norepinephrine; Propanolamines; Receptors, Adrenergic, beta; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-3 | 1999 |
[Pharmacological analysis of atypical beta-adrenoceptors in the guinea pig gastrointestinal tissue systems].
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Digestive System; Duodenum; Epinephrine; Ethanolamines; Gastric Fundus; Guinea Pigs; Ileum; Isoproterenol; Male; Muscle Relaxation; Norepinephrine; Propanolamines; Receptors, Adrenergic, beta | 1999 |
Partial agonist activity of carteolol on atypical beta-adrenoceptors in the guinea pig duodenum.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Carteolol; Dose-Response Relationship, Drug; Duodenum; Epinephrine; Ethanolamines; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Muscle Relaxation; Norepinephrine; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Vasodilator Agents | 2000 |
(+/-)-Pindolol acts as a partial agonist at atypical beta-adrenoceptors in the guinea pig duodenum.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-3 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Catecholamines; Duodenum; Ethanolamines; Guinea Pigs; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth; Pindolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta | 2001 |
Functional identification of beta3-adrenoceptors in the guinea-pig ileum using the non-selective beta-adrenoceptor antagonist (+/-)-bupranolol.
Topics: Adipocytes; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Catecholamines; Dogs; Ethanolamines; Guinea Pigs; Ileum; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth; Propanolamines; Rats; Receptors, Adrenergic, beta-3 | 2000 |
Functional properties of atypical beta-adrenoceptors on the guinea pig duodenum.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Alprenolol; Animals; Bupranolol; Carteolol; Clenbuterol; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Duodenum; Epinephrine; Ethanolamines; Fenoterol; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Muscle Relaxation; Nadolol; Norepinephrine; Phenylephrine; Pindolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Stereoisomerism | 2001 |
ALpha1-adrenoceptor antagonist properties of CGP 12177A and other beta-adrenoceptor ligands: evidence against beta(3)- or atypical beta-adrenoceptors in rat aorta.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-Antagonists; Alprenolol; Animals; Aorta, Thoracic; Binding Sites; Bupranolol; Cell Membrane; Cerebral Cortex; Dose-Response Relationship, Drug; Ethanolamines; Imidazoles; Male; Muscle, Smooth, Vascular; Phenylephrine; Pindolol; Prazosin; Propanolamines; Propranolol; Radioligand Assay; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta-3; Tritium; United Kingdom; Vasoconstriction | 2004 |
Endothelial beta3-adrenoceptors mediate vasorelaxation of human coronary microarteries through nitric oxide and endothelium-dependent hyperpolarization.
Topics: Adolescent; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Apamin; Arterioles; Bupranolol; Charybdotoxin; Child; Coronary Vessels; Endothelium, Vascular; Ethanolamines; Female; Humans; Isoproterenol; Male; Membrane Potentials; Microcirculation; Microscopy, Video; Middle Aged; Nadolol; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitroarginine; Potassium Channel Blockers; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3; RNA, Messenger; Vasodilation | 2004 |
Inconsistent role of nitric oxide on lipolysis in isolated rat adipocytes.
Topics: Adipocytes; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bucladesine; Bupranolol; Cell Separation; Cells, Cultured; Cyclic AMP; Ethanolamines; In Vitro Techniques; Lipolysis; Lipopolysaccharides; Male; Nitric Oxide; Nitric Oxide Donors; Proteins; Rats; Rats, Wistar; S-Nitroso-N-Acetylpenicillamine; Signal Transduction; Tetrazolium Salts; Thiazoles | 2005 |
Comparison of the alpha-adrenoceptor-mediated effects of beta3-adrenoceptor ligands in rat pulmonary artery.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Dioxoles; Ethanolamines; In Vitro Techniques; Ligands; Male; Propanolamines; Pulmonary Artery; Rats; Rats, Wistar; Receptors, Adrenergic, beta-3; Vasodilation | 2005 |
Functional coupling of beta3-adrenoceptors and large conductance calcium-activated potassium channels in human uterine myocytes.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Bupranolol; Dose-Response Relationship, Drug; Electrophysiology; Ethanolamines; Female; Humans; In Vitro Techniques; Isometric Contraction; Membrane Potentials; Muscle Cells; Muscle Relaxation; Myometrium; Oxytocin; Peptides; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Propanolamines; Receptors, Adrenergic, beta-3; Uterine Contraction; Uterus | 2005 |
The effects and selectivity of beta-adrenoceptor agonists in rat myometrium and urinary bladder.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-3 Receptor Agonists; Adrenergic beta-3 Receptor Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Bupranolol; Dioxoles; Dose-Response Relationship, Drug; Ethanolamines; Female; In Vitro Techniques; Muscle Contraction; Muscle Relaxation; Myometrium; Oxytocics; Oxytocin; Potassium Chloride; Propanolamines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3; Ritodrine; Urinary Bladder; Uterine Contraction | 2007 |
Influence of β2- and β3-adrenoceptor agonists on contractile activity of the porcine myometrium in the luteal phase and the first days of pregnancy.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-3 Receptor Agonists; Albuterol; Animals; Bupranolol; Butoxamine; Corpus Luteum; Drug Interactions; Ethanolamines; Female; Myometrium; Pregnancy; Pregnancy, Animal; Swine; Uterine Contraction | 2017 |